Paul Edward Walker's Net Worth
Paul Edward Walker's net worth is estimated to be at least $62,142,382.15 as of 05/03/2024. CoreStreet's estimation of Paul Edward Walker's net worth is based on their sale of stock and current holding of stock.
Paul Edward Walker is Director at Allakos Inc. They have executed at least 9 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,984,000 units of ALLK stock on 09/21/2022. Their biggest sale was on 12/31/2020 when they sold 103,415 units of Allakos Inc stock for $14,611,505.35. They typically trade 3 times per year.
Total value of insider buys:
- $46,620,146.39
Total value of insider sells:
- $15,522,235.76
Most recent insider trade:
- Sept. 21, 2022
Paul Edward Walker's Insider Trading History
| Allakos Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 21, 2022 | Director | 3,984,000 | $5.02 | Buy | $19,999,680.00 |
Dec. 31, 2020 | Director | 103,415 | $141.29 | Sell | $14,611,505.35 |
| Genocea Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 24, 2022 | Major Shareholder | 5,931,843 | $0.07 | Sell | $415,229.01 |
July 24, 2020 | Major Shareholder | 3,151,260 | $2.25 | Buy | $7,090,335.00 |
| Trevi Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 11, 2022 | Major Shareholder | 3,580,526 | $1.90 | Buy | $6,802,999.40 |
| Metacrine Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 22, 2021 | Major Shareholder | 459,700 | $0.97 | Sell | $445,909.00 |
Dec. 10, 2021 | Major Shareholder | 37,570 | $1.32 | Sell | $49,592.40 |
| Marker Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 16, 2021 | Major Shareholder | 5,714,285 | $1.75 | Buy | $9,999,998.75 |
| Regulus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 4, 2020 | Major Shareholder | 4,398,602 | $0.62 | Buy | $2,727,133.24 |